Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4674 is a short (20–24 nucleotides) non-coding RNA molecule belonging to the microRNA class[5]. Like other microRNAs, it is produced by sequential cleavage of a longer primary transcript (pri-miRNA) by Drosha and Dicer enzymes, resulting in a mature miRNA that can base-pair imperfectly with target mRNAs, primarily leading to translational inhibition or mRNA destabilization[5][3][7]. MicroRNAs regulate extensive gene networks and affect various cellular processes such as proliferation, differentiation, apoptosis, and intracellular signaling, but specific biological roles, disease associations, or direct targeting drugs of MIR4674 remain uncharacterized. Genomic identifiers for MIR4674 include HGNC:41729, NCBI Gene:100616301, Ensembl:ENSG00000265181, and miRBase:hsa-mir-4674[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4674 (MIR4674).